Ottorino Costantini is a Cardiology physician affiliated with Summa Health System. OpenAlex indexes 27 publications with 354 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2500 N Metrohealth Drive
Cleveland, OH 44109
Telephone
216-778-8765Registry record last updated 8 Jul 2007.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Boston Scientific CorporationProgram year20252 payments
- Medtronic, Inc.Program year20242 payments
- Boston Scientific CorporationProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
75.8%Beta blocker21.5%Metoprolol Succinate69%Metoprolol Tartrate31%Part D≥49 patientsCalcium channel blocker16.6%Diltiazem 24hr Er (Cd)71%Amlodipine Besylate29%Part D≥28 patients+ 7 more classes in this area
Blood & clotting
21.6%Factor Xa inhibitor21.6%Eliquis100%Part D≥48 patientsMetabolism & gastrointestinal
2.6%SGLT2 inhibitor2.6%Farxiga100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- OXALIPLATIN-INDUCED ACQUIRED LONG-QT SYNDROME CAUSING POLYMORPHIC VENTRICULAR TACHYCARDIA
Journal of the American College of Cardiology
2025 - ARRHYTHMOGENIC GENOTYPE-NEGATIVE CARDIOMYOPATHY: IS CARDIAC MRI PHENOTYPE ENOUGH FOR A DIAGNOSIS?
Journal of the American College of Cardiology
2025 - CARDIAC CONDUCTION ABNORMALITIES IN MICROSCOPIC POLYANGIITIS: A REVERSIBLE YET CRITICAL MANIFESTATION
Journal of the American College of Cardiology
2025 - UNEXPLAINED CARDIAC ARREST PRECEDES NONISCHEMIC CARDIOMYOPATHY IN A RARE TRIADIN GENE MUTATION CARRIER
Journal of the American College of Cardiology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Thomas File, MD
Summa Health System
Marc Penn, MD
Summa Health System
Drazen Petrinec, MD
Summa Health System
Sameer Mahesh, MD
Summa Health System
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”